N
LLY icon

Natixis’s Eli Lilly LLY Stock Holding History

Natixis’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-7
Closed -$2K – 1240
2022
Q3 		$2K Sell
7
-5
-42% -$1.58K ﹤0.01% 1046
2022
Q2 		$4K Buy
+12
New +$3.6K ﹤0.01% 1102

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Natixis's LLY Position: Q2 2026 in Review

Natixis increased its Eli Lilly (LLY) stake by 32% in Q2 2026, buying an estimated $33.2M and bringing the position to 133,441 shares worth $160M. The position accounts for 0.64% of the portfolio, ranked #24.

Natixis first reported a position in LLY in Q2 2013 and has held it in 45 quarters since. The position peaked at $267M in Q1 2025. 4,624 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Natixis held 133,441 shares of Eli Lilly worth $160M as of Q2 2026.
  • Natixis bought 32,494 Eli Lilly shares in Q2 2026, an estimated $33.2M.
  • Eli Lilly made up 0.64% of Natixis's portfolio in Q2 2026, its #24 holding.
  • Natixis first reported a position in Eli Lilly in Q2 2013 and has held it in 45 quarters since.
  • Natixis's Eli Lilly position peaked at $267M in Q1 2025.
  • 4,624 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Natixis's 13F filing for Q2 2026, filed 13 Aug 2026.